Interest of pharmacovigilance in oncology: examples with oral cancer chemotherapies

被引：0

|

作者：

Broussard, P.

Fournier-Choma, C.

Zenut, M.

Eschalier, A.

Doly, M.

机构：

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2008年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

97

引用

收藏

页码：21 / 21

页数：1

相关论文

共 50 条

[31] Pharmacovigilance in oncology: evaluation of current practice and future perspectives
Baldo, Paolo
De Paoli, Paolo
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2014, 20 (05) : 559 - 569
[32] Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
Francescon, Sara
Fornasier, Giulia
Baldo, Paolo
ONCOLOGY AND THERAPY, 2016, 4 (02) : 173 - 182
[33] Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs
Arora, Ankur
Jalali, Rajinder K.
Vohora, Divya
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 1195 - 1203
[34] Patient preferences for chemotherapies used in breast cancer
Beusterien, K.
Grinspan, J.
Tencer, T.
Brufsky, A.
Visovsky, C.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[35] Repurposing existing medications in oncology and their potential role in oral cancer
Basile, J. R.
Czerninski, R.
ORAL DISEASES, 2019, 25 (01) : 6 - 9
[36] DIFFERING INTERPRETATIONS OF CANCER TERMINOLOGY - IMPLICATIONS FOR ORAL ONCOLOGY EDUCATION
RODU, B
WEAVER, B
MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (06): : A32 - A32
[37] Designing a payment system to support cancer care coordination and improve patient adherence to oral chemotherapies: A literature review
Girault, Anne
Gerves-Pinquie, Chloe
Minvielle, Etienne
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[38] Holistic care for patients with cancer: A new paradigm for integrating oral medicine and oral oncology services in cancer centers
Villa, Alessandro
Pons, Maggy
Davis, Mark
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2024, 155 (12):
[39] Treatment cost of colorectal cancer chemotherapies in Germany
Hieke, K
Grothey, A
VALUE IN HEALTH, 2005, 8 (06) : A39 - A40
[40] Oral granisetron versus oral ondansetron for the prevention of nausea vomiting induced by moderately emetogenic chemotherapies
Huc, P
Block, S
Carlier, D
Darloy, F
Bonneterre, ME
Bleuse, JP
Fournier, C
Bonneterre, J
BULLETIN DU CANCER, 1998, 85 (06) : 562 - 568

← 1 2 3 4 5 →